Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time

Health and Quality of Life Outcomes

Volumn 14, Issue 1, 2016, Pages

  Ousmen, Ahmad ^a,b   Conroy, Thierry ^c,d   Guillemin, Francis ^d,e   Velten, Michel ^d,f   Jolly, Damien ^d,g   Mercier, Mariette ^b,d   Causeret, Sylvain ^h   Cuisenier, Jean ^h   Graesslin, Olivier ^g   Hamidou, Zeinab ^d,i   Bonnetain, Franck ^a,b,d   Anota, Amélie ^a,b,d  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c CENTRE ALEXIS VAUTRIN   (France)

^d French National Platform of Quality of Life and Cancer   (France)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

^f UNIVERSITÉ DE STRASBOURG   (France)

^g REIMS UNIVERSITY HOSPITAL   (France)

^h CENTRE GEORGES FRANÇOIS LECLERC   (France)

ⁱ AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Anchor based method; Health related quality of life; Minimal important difference; Response shift; Then test

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER PATIENT; DETERIORATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; MINIMAL IMPORTANT DIFFERENCE; PARAMETERS; QUALITY OF LIFE; QUESTIONNAIRE; RESPONSE SHIFT; AGED; BREAST TUMOR; FACTOR ANALYSIS; LONGITUDINAL STUDY; PSYCHOLOGY; PSYCHOMETRY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; BREAST NEOPLASMS; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES;

EID: 85000916299     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-016-0569-5     Document Type: Article

References (26)

1. Liang MH. Longitudinal construct validity: establishment of clinical meaning in patient evaluative instruments. Med Care. 2000;38:II84-90.
2. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139-44.
3. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407-15.
4. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol. 1994;47:81-7.
5. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003;56:395-407.
6. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61:102-9.
7. Maringwa JT, Quinten C, King M, Ringash J, Osoba D, Coens C, Martinelli F, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, Taphoorn MJ, Reeve BB, Koch JS-V, Weis J, Smit EF, van Meerbeeck JP, Bottomley A, Group on behalf of the EP project and the LC. Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer. 2010;19:1753-60.
8. Maringwa J, Quinten C, King M, Ringash J, Osoba D, Coens C, Martinelli F, Reeve BB, Gotay C, Greimel E, Flechtner H, Cleeland CS, Koch JS-V, Weis J, Bent MJVD, Stupp R, Taphoorn MJ, Bottomley A, Group on behalf of the EPP and BC. Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol. 2011;22:2107-12.
9. Sprangers MAG, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med. 1999;48:1507-15.
10. Schwartz CE, Sprangers MAG. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 1999;48:1531-48.
11. Oort FJ. Using structural equation modeling to detect response shifts and true change. Qual Life Res. 2005;14:587-98.
12. Hamidou Z, Dabakuyo-Yonli TS, Guillemin F, Conroy T, Velten M, Jolly D, Causeret S, Graesslin O, Gauthier M, Mercier M, Bonnetain F. Impact of response shift on time to deterioration in quality of life scores in breast cancer patients. PLoS One. 2014;9:e96848.
13. Kvam AK, Wisløff F, Fayers PM. Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma. Health Qual Life Outcomes. 2010;8:79.
14. Dabakuyo TS, Guillemin F, Conroy T, Velten M, Jolly D, Mercier M, Causeret S, Cuisenier J, Graesslin O, Gauthier M, Bonnetain F. Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study. Qual Life Res. 2012;22:1-11.
15. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F. The European Organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-76.
16. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D. Bottomley AobotEQoLG. In: EORTC QLQ-C30 Scoring Manual. 3rd edition. EORTC; 2001. edn; 2001.
17. Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, et al. The European Organization for Research and Treatment of Cancer breast cancer-specificquality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14:2756-68.
18. Sprangers M, Van Dam F, Broersen J, Lodder L, Wever L, Visser M, Oosterveld P, Smets E. Revealing response shift in longitudinal research on fatigue--the use of the thentest approach. Acta Oncol. 1999;38:709-18.
19. Anota A, Bascoul-Mollevi C, Guillemin F, Conroy T, Velten M, Joly D, Mercier M, Graesslin O, Causeret S, Cuisenier J, Hamidou Z, Bonnetain F. Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients. Health Qual Life Outcomes. 2014;12:32.
20. Kazis L, Anderson J, Meenan R. Effect sizes for interpreting changes in health status. Med Care. 1989;27:178-89.
21. Development Core Team R. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. URL http://www.R-project.org/.
22. Cocks K, Cohen D, Wisløff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A, Graham L, Phillips A, Stead M, Velikova G, Brown J. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer. 2007;43:1670-8.
23. Oort FJ, Visser MRM, Sprangers MAG. An application of structural equation modeling to detect response shifts and true change in quality of life data from cancer patients undergoing invasive surgery. Qual Life Res. 2005;14:599-609.
24. th Annual Conference of the International Society for Quality of Life Research (ISOQOL), 15-18 October 2014, Berlin (Germany).
25. Bonnetain F, Dahan L, Maillard E, Ychou M, Mitry E, Hammel P, Legoux J-L, Rougier P, Bedenne L, Seitz J-F. Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma. Eur J Cancer. 2010;46:2753-62.
26. Hamidou Z, Dabakuyo TS, Bonnetain F. Impact of response shift on longitudinal quality-of-life assessment in cancer clinical trials. Expert Rev Pharmacoecon Outcomes Res. 2011;11:549-59.